Pamisell has ranked among the top searched stocks for 7 days in the past month.


As of 10:30 AM on the 28th, Pamisell is trading at 22,350 KRW, down 1.32% from the previous day. This represents a 7.45% increase compared to August 21. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Today, foreigners are tentatively recorded as net buyers of 60,000 shares. Over the past 5 days, individual investors have net purchased 417,781 shares, while foreigners and institutions have net sold 537,452 shares and net purchased 106,351 shares, respectively.




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing